Melatonin Use in Kids Surges Despite Limited Safety Data, Doctors Warn

Melatonin supplementation in children has exploded in popularity as families seek natural solutions for increasingly common sleep difficulties. Parents are drawn to its accessibility, child-friendly formulations, and perception as a safer alternative to prescription medications. However, this widespread adoption has significantly outpaced the scientific evidence base for pediatric use.

A comprehensive review published in World Journal of Pediatrics by Boston Children's Hospital researchers reveals a stark mismatch between melatonin's popularity and available long-term safety data. The analysis found robust clinical evidence supporting short-term benefits specifically for children with neurodevelopmental disorders like autism and ADHD, where melatonin helps reduce sleep onset time, extend total sleep duration, and improve caregiver quality of life.

Critically, evidence remains limited for typical childhood insomnia in neurotypical children. This gap is concerning given melatonin's role as a hormone affecting multiple body systems beyond sleep regulation, including immune function, metabolism, and reproductive processes. The review highlighted additional safety concerns including inconsistent dosing in over-the-counter products, unsupervised use without medical guidance, and rising rates of accidental ingestion among young children.

The findings underscore the need for stronger regulatory oversight of pediatric sleep supplements and evidence-based prescribing guidelines. Researchers emphasize that melatonin should be used cautiously and only alongside proven behavioral sleep interventions. For families considering melatonin, medical supervision is essential to ensure appropriate dosing, timing, and monitoring for potential side effects, particularly given the limited understanding of long-term developmental impacts in growing children.